News
IBL International GmbH, a Tecan company, which develops, manufactures and offers specialty diagnostics, today announced a strategic partnership with Grifols, a global healthcare company and ...
About 300 donations have been made at Grifols Hamilton since it opened on March 10 at 2255 Barton St. E. after receiving licensing through Health Canada. Joanna Frketich is the health reporter for ...
Canadian fund Brookfield BAM-T said on Wednesday it has dropped its plan to take over Spain’s Grifols due to a disagreement over the pharmaceutical company’s value. Brookfield had filed a non ...
Private equity firm Brookfield has said it is withdrawing from negotiations to take over Grifols, sparking a slump in the Spanish pharma group's share price. The Canadian investment group said it ...
The family that owns Spanish drugmaker Grifols and private equity firm Brookfield are considering whether to take the company private in a deal that could be worth around €5.5 billion (almost $6 ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Credit: Unai Huizi Photography / Shutterstock. IBL International has entered a strategic collaboration with healthcare company Grifols to develop biomarker panels for speciality diagnostics. Through ...
If you’re on the fence about investing in Alvotech, Grifols or S.A. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision. Read on to ...
Grifols and IBL, a Tecan company, seek to revolutionize clinical diagnostics with a future high-sensitivity, multiplexed immunoassay platform Männedorf, Switzerland, April 8, 2025 – IBL International ...
At close: April 15 at 4:00:02 PM EDT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results